Cryo-Cell International, Inc. (CCEL)
USD 4.85
(-6.73%)
USD 4.85
(-6.73%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 31.34 Million USD | 3.32% |
| 2022 | 30.33 Million USD | 5.03% |
| 2021 | 28.88 Million USD | -7.26% |
| 2020 | 31.14 Million USD | -2.1% |
| 2019 | 31.81 Million USD | 8.89% |
| 2018 | 29.21 Million USD | 15.1% |
| 2017 | 25.38 Million USD | 9.76% |
| 2016 | 23.12 Million USD | 9.66% |
| 2015 | 21.09 Million USD | 4.79% |
| 2014 | 20.12 Million USD | 5.96% |
| 2013 | 18.99 Million USD | 5.7% |
| 2012 | 17.96 Million USD | 0.29% |
| 2011 | 17.91 Million USD | 1.58% |
| 2010 | 17.63 Million USD | 8.04% |
| 2009 | 16.32 Million USD | -5.51% |
| 2008 | 17.27 Million USD | -1.04% |
| 2007 | 17.46 Million USD | 1.63% |
| 2006 | 17.18 Million USD | 18.88% |
| 2005 | 14.45 Million USD | 18.35% |
| 2004 | 12.21 Million USD | 61.74% |
| 2003 | 7.54 Million USD | 6.74% |
| 2002 | 7.07 Million USD | 25.22% |
| 2001 | 5.64 Million USD | 167.78% |
| 2000 | 2.1 Million USD | 24.08% |
| 1999 | 1.7 Million USD | 466.67% |
| 1998 | 300 Thousand USD | -25.0% |
| 1997 | 400 Thousand USD | -85.19% |
| 1996 | 2.7 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 7.85 Million USD | -0.31% |
| 2024 Q2 | 8.04 Million USD | 2.43% |
| 2024 Q3 | 8.06 Million USD | 0.3% |
| 2023 Q2 | 7.77 Million USD | -0.66% |
| 2023 Q1 | 7.82 Million USD | 0.78% |
| 2023 Q4 | 7.87 Million USD | 0.09% |
| 2023 FY | 31.34 Million USD | 3.32% |
| 2023 Q3 | 7.86 Million USD | 1.25% |
| 2022 Q3 | 7.68 Million USD | 0.63% |
| 2022 FY | 30.33 Million USD | 5.03% |
| 2022 Q1 | 7.25 Million USD | -0.78% |
| 2022 Q2 | 7.63 Million USD | 5.16% |
| 2022 Q4 | 7.76 Million USD | 1.08% |
| 2021 Q1 | 6.86 Million USD | -9.02% |
| 2021 Q4 | 7.31 Million USD | -2.51% |
| 2021 Q2 | 7.2 Million USD | 5.02% |
| 2021 FY | 28.88 Million USD | -7.26% |
| 2021 Q3 | 7.5 Million USD | 4.14% |
| 2020 Q4 | 7.54 Million USD | -7.07% |
| 2020 Q2 | 7.87 Million USD | 3.29% |
| 2020 Q1 | 7.62 Million USD | -4.38% |
| 2020 FY | 31.14 Million USD | -2.1% |
| 2020 Q3 | 8.11 Million USD | 3.08% |
| 2019 Q4 | 7.97 Million USD | -3.08% |
| 2019 Q2 | 8.12 Million USD | 8.44% |
| 2019 Q3 | 8.22 Million USD | 1.18% |
| 2019 Q1 | 7.49 Million USD | -12.78% |
| 2019 FY | 31.81 Million USD | 8.89% |
| 2018 Q3 | 7.87 Million USD | 20.62% |
| 2018 FY | 29.21 Million USD | 15.1% |
| 2018 Q4 | 8.59 Million USD | 9.18% |
| 2018 Q2 | 6.52 Million USD | 4.77% |
| 2018 Q1 | 6.22 Million USD | -3.81% |
| 2017 FY | 25.38 Million USD | 9.76% |
| 2017 Q2 | 6.23 Million USD | 7.97% |
| 2017 Q3 | 6.89 Million USD | 10.57% |
| 2017 Q4 | 6.47 Million USD | -6.1% |
| 2017 Q1 | 5.77 Million USD | -1.61% |
| 2016 Q1 | 5.15 Million USD | -11.14% |
| 2016 Q3 | 6.33 Million USD | 9.68% |
| 2016 Q2 | 5.77 Million USD | 12.05% |
| 2016 Q4 | 5.87 Million USD | -7.28% |
| 2016 FY | 23.12 Million USD | 9.66% |
| 2015 Q1 | 4.84 Million USD | -2.65% |
| 2015 Q2 | 5.01 Million USD | 3.52% |
| 2015 Q3 | 5.43 Million USD | 8.42% |
| 2015 FY | 21.09 Million USD | 4.79% |
| 2015 Q4 | 5.79 Million USD | 6.66% |
| 2014 FY | 20.12 Million USD | 5.96% |
| 2014 Q3 | 4.93 Million USD | 0.92% |
| 2014 Q4 | 4.97 Million USD | 0.76% |
| 2014 Q2 | 4.89 Million USD | -8.04% |
| 2014 Q1 | 5.32 Million USD | 13.05% |
| 2013 FY | 18.99 Million USD | 5.7% |
| 2013 Q1 | 4.6 Million USD | -4.63% |
| 2013 Q2 | 4.85 Million USD | 5.62% |
| 2013 Q3 | 4.82 Million USD | -0.6% |
| 2013 Q4 | 4.7 Million USD | -2.55% |
| 2012 Q1 | 4.17 Million USD | -5.81% |
| 2012 FY | 17.96 Million USD | 0.29% |
| 2012 Q4 | 4.82 Million USD | 6.19% |
| 2012 Q3 | 4.54 Million USD | 2.64% |
| 2012 Q2 | 4.42 Million USD | 5.91% |
| 2011 Q1 | 4.47 Million USD | -1.92% |
| 2011 Q3 | 4.4 Million USD | -4.2% |
| 2011 FY | 17.91 Million USD | 1.58% |
| 2011 Q4 | 4.43 Million USD | 0.65% |
| 2011 Q2 | 4.6 Million USD | 2.87% |
| 2010 Q2 | 4.3 Million USD | 1.57% |
| 2010 Q3 | 4.53 Million USD | 5.47% |
| 2010 Q1 | 4.23 Million USD | 5.62% |
| 2010 Q4 | 4.56 Million USD | 0.48% |
| 2010 FY | 17.63 Million USD | 8.04% |
| 2009 Q3 | 4.2 Million USD | -0.79% |
| 2009 Q1 | 3.86 Million USD | -6.51% |
| 2009 Q2 | 4.24 Million USD | 9.75% |
| 2009 Q4 | 4.01 Million USD | -4.68% |
| 2009 FY | 16.32 Million USD | -5.51% |
| 2008 Q4 | 4.13 Million USD | -7.26% |
| 2008 Q1 | 4.17 Million USD | -2.72% |
| 2008 Q2 | 4.51 Million USD | 8.28% |
| 2008 Q3 | 4.45 Million USD | -1.27% |
| 2008 FY | 17.27 Million USD | -1.04% |
| 2007 Q4 | 4.28 Million USD | -5.78% |
| 2007 FY | 17.46 Million USD | 1.63% |
| 2007 Q1 | 4.17 Million USD | -5.56% |
| 2007 Q2 | 4.44 Million USD | 6.6% |
| 2007 Q3 | 4.55 Million USD | 2.27% |
| 2006 Q3 | 4.58 Million USD | 2.43% |
| 2006 Q4 | 4.41 Million USD | -3.7% |
| 2006 Q2 | 4.48 Million USD | 21.38% |
| 2006 Q1 | 3.69 Million USD | -3.79% |
| 2006 FY | 17.18 Million USD | 18.88% |
| 2005 Q1 | 3.26 Million USD | 1.91% |
| 2005 Q2 | 3.57 Million USD | 9.36% |
| 2005 Q4 | 3.83 Million USD | 1.71% |
| 2005 Q3 | 3.77 Million USD | 5.53% |
| 2005 FY | 14.45 Million USD | 18.35% |
| 2004 Q3 | 3.22 Million USD | 1.03% |
| 2004 Q1 | 2.57 Million USD | 4.87% |
| 2004 Q4 | 3.2 Million USD | -0.69% |
| 2004 Q2 | 3.19 Million USD | 23.99% |
| 2004 FY | 12.21 Million USD | 61.74% |
| 2003 Q3 | 2.02 Million USD | 24.24% |
| 2003 FY | 7.54 Million USD | 6.74% |
| 2003 Q1 | 1.43 Million USD | -24.75% |
| 2003 Q4 | 2.45 Million USD | 21.2% |
| 2003 Q2 | 1.63 Million USD | 14.1% |
| 2002 Q3 | 1.89 Million USD | 5.7% |
| 2002 Q1 | 1.48 Million USD | -7.29% |
| 2002 Q2 | 1.79 Million USD | 20.71% |
| 2002 FY | 7.07 Million USD | 25.22% |
| 2002 Q4 | 1.9 Million USD | 0.36% |
| 2001 Q4 | 1.6 Million USD | 13.23% |
| 2001 Q3 | 1.41 Million USD | -24.4% |
| 2001 Q2 | 1.87 Million USD | 145.64% |
| 2001 Q1 | 761.61 Thousand USD | 25.05% |
| 2001 FY | 5.64 Million USD | 167.78% |
| 2000 FY | 2.1 Million USD | 24.08% |
| 2000 Q4 | 609.07 Thousand USD | 9.82% |
| 2000 Q3 | 554.62 Thousand USD | -8.1% |
| 2000 Q2 | 603.53 Thousand USD | 41.71% |
| 2000 Q1 | 425.9 Thousand USD | -46.76% |
| 1999 Q2 | 300 Thousand USD | 50.0% |
| 1999 Q1 | 200 Thousand USD | 100.0% |
| 1999 Q4 | 800 Thousand USD | 166.67% |
| 1999 Q3 | 300 Thousand USD | 0.0% |
| 1999 FY | 1.7 Million USD | 466.67% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 FY | 300 Thousand USD | -25.0% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q1 | 400 Thousand USD | -33.33% |
| 1997 Q2 | 100 Thousand USD | -75.0% |
| 1997 FY | 400 Thousand USD | -85.19% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 700 Thousand USD | 0.0% |
| 1996 Q3 | 700 Thousand USD | 0.0% |
| 1996 Q4 | 600 Thousand USD | -14.29% |
| 1996 FY | 2.7 Million USD | 0.0% |
| 1996 Q1 | 700 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 98.93% |
| Addus HomeCare Corporation | 1.05 Billion USD | 97.039% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | 84.002% |
| Amedisys, Inc. | 2.23 Billion USD | 98.598% |
| Astrana Health, Inc. | 1.38 Billion USD | 97.74% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 98.346% |
| IMAC Holdings, Inc. | 5.19 Million USD | -503.111% |
| biote Corp. | 185.36 Million USD | 83.09% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 98.448% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 94.979% |
| The Ensign Group, Inc. | 3.72 Billion USD | 99.16% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 98.125% |
| InnovAge Holding Corp. | 763.85 Million USD | 95.897% |
| The Joint Corp. | 117.69 Million USD | 73.369% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 97.031% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -202.589% |
| ModivCare Inc. | 2.75 Billion USD | 98.861% |
| NewGenIvf Group Limited | 5.13 Million USD | -510.256% |
| Option Care Health, Inc. | 4.3 Billion USD | 99.271% |
| P3 Health Partners Inc. | 1.26 Billion USD | 97.525% |
| P3 Health Partners Inc. | 1.26 Billion USD | 97.525% |
| The Pennant Group, Inc. | 544.89 Million USD | 94.248% |
| Surgery Partners, Inc. | 2.74 Billion USD | 98.857% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -468.321% |
| Talkspace, Inc. | 150.04 Million USD | 79.11% |
| Talkspace, Inc. | 150.04 Million USD | 79.11% |
| The Oncology Institute, Inc. | 324.23 Million USD | 90.333% |
| The Oncology Institute, Inc. | 324.23 Million USD | 90.333% |